Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 281-290 of 314 for infectious diseases

Edit search filters
  1. Characterizing HIV-related Diastolic Dysfunction

    Rochester, MN

  2. Outcomes following treatment of the infected Achilles tendon

    Rochester, MN

  3. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C

    Rochester, MN

  4. Immune Cell Activation of Healthy Human Subjects

    Rochester, MN

  5. A Study of the Efficacy of Initial Diagnosis of H Pylori with Tech Lab Quik Chek and Efficacy of H. Pylori Chek on Patients that Have Been Treated for H Pylori

  6. Laboratory Assay Optimization 2.0

    Rochester, MN

  7. A Study of the Characteristics and Outcomes of Treatment for C. Diff in Post-Transplant Patients

    Rochester, MN

  8. A Registry for Cirrhosis that has a Sustained Virologic Response Following Sofosbuvir-Based Treatment without Interferon, for Patients who have Chronic Hepatitis C Infection

    Rochester, MN

  9. Studying Biomarkers in Diagnosing Cervical Lesions in Patients with Abnormal Cervical Cells

    Rochester, MN

  10. BK Virus Immunity in Kidney Transplant

    Rochester, MN

.

Mayo Clinic Footer